Biotech, Pharmaceutical & Medical Equipment Auctions & Asset Sales

Ongoing modernization within biotech, pharmaceutical, and medical operations results in surplus laboratory, production, and facility assets as research priorities shift, products reach end of life, and manufacturing footprints evolve. Heritage Global Partners has a long track record supporting asset dispositions within this sector for research laboratories, clinical operations, and regulated manufacturing facilities, including surplus laboratory equipment sales and complete facility liquidations, frequently spanning multiple operational sites.

Heritage Global Partners maintains exclusive master service agreements with Pfizer and Amgen for the disposition of surplus biotech and pharmaceutical assets. Sales in this category originate from research and development transitions, facility consolidations, and corporate restructuring, supporting buyers active in regulated scientific and healthcare environments.

Typical Assets Sold

Current Auctions

CytoImmune
Cell Therapy & Bioprocessing Equipment: Flow Cytometry, Cell Processing Systems, Irradiation, PCR Instruments, Cryo Systems & More! Corozal, PR.

Starting: Jun 11th, 2026 7:00am EDT

Ending: Jun 12th, 2026 12:00pm EDT

Immediately Accepting Bids

Past Auctions

Anika
Global Online Auction Of Surplus BioPharma Lab & Process Equipment Formerly Owned by Anika Therapeutics, A Global Medical Technology Company.

Starting: May 6th, 2019 7:00am EDT

Ending: May 8th, 2019 11:00am EDT

Immediately Accepting Bids
Synthetic Genomics
Global Online Auction Featuring Exceptional Lab Equipment Surplus To Continuing Operations Of Synthetic Genomics. San Diego, CA.

Starting: May 2nd, 2019 7:00am PDT

Ending: May 3rd, 2019 10:00am PDT

Immediately Accepting Bids
Pfizer
The 78th in a series of Online Sales Featuring State-of-the-Art BioPharma Lab Equipment from the World’s Largest Pharmaceutical Manufacturer.

Starting: Apr 24th, 2019 7:00am PDT

Ending: Apr 25th, 2019 9:00am PDT

Immediately Accepting Bids
Pfizer
The 76th in a series of Online Sales Featuring State-of-the-Art BioPharma Lab Equipment from the World’s Largest Pharmaceutical Manufacturer.

Starting: Mar 27th, 2019 7:00am PDT

Ending: Mar 28th, 2019 9:00am PDT

Immediately Accepting Bids

Managing surplus lab or regulated manufacturing assets?

Buyer FAQs

Many cleanroom components, HVAC systems, and lab assets can be reused in non-GMP or pilot-scale applications with modification.
Buyers should evaluate service history, manufacturer support status, software compatibility, and calibration requirements.
Validation documentation may be available when provided by the seller and is disclosed within the listing of assets for sale.

Seller FAQs

Sales are often structured to align with internal QA, EHS, and compliance teams prior to equipment release.
Yes. Asset-only dispositions can be structured without referencing product names or research outcomes.

Sales are often driven by pipeline changes, site consolidations, regulatory strategy shifts, or the retirement of specific research or production programs.